Literature DB >> 1323493

High expression of stathmin in multipotential teratocarcinoma and normal embryonic cells versus their early differentiated derivatives.

V Doye1, O Kellermann, M H Buc-Caron, A Sobel.   

Abstract

Stathmin is a ubiquitous cytoplasmic protein, phosphorylated in response to agents regulating the proliferation, the differentiation and the specialized functions of cells, in a way possibly integrating the actions of diverse concomitant regulatory signals. Its expression is also regulated in relation with cell proliferation and differentiation and reaches a peak at the neonatal stage. To assess the possible role of stathmin at earlier stages of development, we examined its expression and regulation in embryonal carcinoma (EC) and derived cell lines as well as in the early mouse embryo. Interestingly, stathmin is highly abundant in the undifferentiated, multipotential cells of the F9, 1003 and 1009 EC cell lines. Its high expression markedly decreased, both at the protein and mRNA levels, when F9 cells were induced to differentiate into endodermal-like cells with retinoic acid and dibutyryl-cAMP. Stathmin was also much less abundant in differentiated cell lines such as the trophectodermal line TDM-1, as well as in several F9- and 1003-derived cell lines committed to differentiate towards the mesodermal and neuroectodermal lineages but still proliferating. Therefore, the observed decrease of stathmin expression is not related to the reduced proliferation rate but rather to the differentiation of the multipotential EC cells. The immunocytochemical pattern of stathmin expression during early mouse development indicated that stathmin is also highly abundant in the multipotential cells of the inner cell mass of the blastula, whereas it is much lower in the differentiated trophectodermal cells. These results confirm the physiological relevance of the observations with EC cells, and suggest that stathmin, in addition to its high expression at later stages of development and in the adult nervous system, may be considered as a new marker of the multipotential cells of the early mouse embryo.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1323493     DOI: 10.1111/j.1432-0436.1992.tb00489.x

Source DB:  PubMed          Journal:  Differentiation        ISSN: 0301-4681            Impact factor:   3.880


  12 in total

1.  Selective disruption of genes transiently induced in differentiating mouse embryonic stem cells by using gene trap mutagenesis and site-specific recombination.

Authors:  I S Thorey; K Muth; A P Russ; J Otte; A Reffelmann; H von Melchner
Journal:  Mol Cell Biol       Date:  1998-05       Impact factor: 4.272

2.  Drosophila stathmins bind tubulin heterodimers with high and variable stoichiometries.

Authors:  Sylvie Lachkar; Marion Lebois; Michel O Steinmetz; Antoine Guichet; Neha Lal; Patrick A Curmi; André Sobel; Sylvie Ozon
Journal:  J Biol Chem       Date:  2010-02-09       Impact factor: 5.157

3.  Stathmin interaction with a putative kinase and coiled-coil-forming protein domains.

Authors:  A Maucuer; J H Camonis; A Sobel
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-11       Impact factor: 11.205

4.  Stathmin levels in growth plate chondrocytes are modulated by vitamin D3 metabolites and transforming growth factor-beta1 and are associated with proliferation.

Authors:  T W Hummert; Z Schwartz; V L Sylvia; D D Dean; B D Boyan
Journal:  Endocrine       Date:  2001-06       Impact factor: 3.633

5.  CD9 is associated with leukemia inhibitory factor-mediated maintenance of embryonic stem cells.

Authors:  Masahiro Oka; Kenichi Tagoku; Thomas L Russell; Yuka Nakano; Takashi Hamazaki; Edwin M Meyer; Takashi Yokota; Naohiro Terada
Journal:  Mol Biol Cell       Date:  2002-04       Impact factor: 4.138

6.  Drosophila stathmin: a microtubule-destabilizing factor involved in nervous system formation.

Authors:  Sylvie Ozon; Antoine Guichet; Olivier Gavet; Siegfried Roth; André Sobel
Journal:  Mol Biol Cell       Date:  2002-02       Impact factor: 4.138

7.  The phosphorylation of stathmin by MAP kinase.

Authors:  I A Leighton; P Curmi; D G Campbell; P Cohen; A Sobel
Journal:  Mol Cell Biochem       Date:  1993-11       Impact factor: 3.396

8.  Expression of transfected stathmin cDNA reveals novel phosphorylated forms associated with developmental and functional cell regulation.

Authors:  V Doye; S Le Gouvello; T Dobransky; H Chneiweiss; L Beretta; A Sobel
Journal:  Biochem J       Date:  1992-10-15       Impact factor: 3.857

9.  Immunohistochemical detection of oncoprotein 18 (Op18) in malignant lymphomas.

Authors:  K Nylander; U Marklund; G Brattsand; M Gullberg; G Roos
Journal:  Histochem J       Date:  1995-02

10.  Molecular characterization of human stathmin expressed in Escherichia coli: site-directed mutagenesis of two phosphorylatable serines (Ser-25 and Ser-63).

Authors:  P A Curmi; A Maucuer; S Asselin; M Lecourtois; A Chaffotte; J M Schmitter; A Sobel
Journal:  Biochem J       Date:  1994-06-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.